Effective asthma management: is it time to let the AIR out of SABA?
A Kaplan, PD Mitchell, AJ Cave, R Gagnon… - Journal of Clinical …, 2020 - mdpi.com
For years, standard asthma treatment has included short acting beta agonists (SABA),
including as monotherapy in patients with mild asthma symptoms. In the Global Initiative for …
including as monotherapy in patients with mild asthma symptoms. In the Global Initiative for …
Future risks in patients with severe asthma
WJ Song, JH Lee, Y Kang, WJ Joung… - Allergy, asthma & …, 2019 - synapse.koreamed.org
A major burden of severe asthma is the future risk of adverse health outcomes. Patients with
severe asthma are prone to serious exacerbation and deterioration of lung function and may …
severe asthma are prone to serious exacerbation and deterioration of lung function and may …
Impact of comorbid asthma on severity of coronavirus disease (COVID-19)
The severity of the coronavirus disease (COVID-19) is associated with various comorbidities.
However, no studies have yet demonstrated the potential risk of respiratory failure and …
However, no studies have yet demonstrated the potential risk of respiratory failure and …
Cold temperature and sudden temperature drop as novel risk factors of asthma exacerbation: a longitudinal study in 18 Chinese cities
Background Few studies have explored the role of ambient temperature in asthma
exacerbation. Objective We aimed to explore the association of temperature with diurnal …
exacerbation. Objective We aimed to explore the association of temperature with diurnal …
Medical costs and productivity loss due to mild, moderate, and severe asthma in the United States
Background Little is known about economic and productivity loss by severity of asthma. We
investigate health-care utilization, direct medical costs, and indirect costs due to productivity …
investigate health-care utilization, direct medical costs, and indirect costs due to productivity …
Manifesto on united airways diseases (UAD): an Interasma (global asthma association–GAA) document
Objective: The large amount of evidence and the renewed interest in upper and lower
airways involvement in infectious and inflammatory diseases has led Interasma (Global …
airways involvement in infectious and inflammatory diseases has led Interasma (Global …
Trajectory analyses of adherence patterns in a real-life moderate to severe asthma population
Background Global Initiative for Asthma step 5 therapies (GINA-5), other than inhaled
corticosteroids and long-acting β-agonists in fixed dose combinations (ICS/LABA FDC) …
corticosteroids and long-acting β-agonists in fixed dose combinations (ICS/LABA FDC) …
The effects of nebulized ketamine and intravenous magnesium sulfate on corticosteroid resistant asthma exacerbation; a randomized clinical trial
K Farshadfar, M Sohooli, R Shekouhi… - Asthma Research and …, 2021 - Springer
Background and aims Asthma exacerbation is defined as an acute attack of shortness of
breath with more than 25% decrease in morning peak flow compared to the baseline on 2 …
breath with more than 25% decrease in morning peak flow compared to the baseline on 2 …
Independent risk factors for death in patients admitted for asthma exacerbation in Taiwan
YL Chang, HK Ko, MS Lu, CL Chou, KC Su… - NPJ Primary Care …, 2020 - nature.com
The independent risk factors for death in patients admitted for asthma exacerbation have not
been thoroughly investigated. This study aimed to investigate these independent risk factors …
been thoroughly investigated. This study aimed to investigate these independent risk factors …
Health-related quality of life and health utilities of mild, moderate, and severe asthma: Evidence from the medical expenditure panel survey
Background Little information is known about the health-related quality of life (HRQOL) and
the patient's preference values by the severity of asthma. We evaluated the HRQOL and …
the patient's preference values by the severity of asthma. We evaluated the HRQOL and …